haloperidol has been researched along with Aggression in 192 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Aggression: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The goal of this study was to assess the effects of clozapine and olanzapine in comparison to the first-generation agent haloperidol on these metabolic parameters in aggressive patients with schizophrenia." | 9.14 | Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. ( Citrome, L; Czobor, P; Krakowski, M, 2009) |
| "As monotherapy, both olanzapine and risperidone were superior to haloperidol and clozapine in reducing aggression." | 9.11 | Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO). ( Bitter, I; Czobor, P; Dossenbach, M; Volavka, J, 2005) |
| "44 patients with chronic DSM-IV schizophrenia were treated with clozapine or haloperidol decanoate in an open prospective 6-month trial." | 9.10 | The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. ( Mester, R; Shabash, E; Sheitman, B; Spivak, B; Weizman, A, 2003) |
| "To evaluate the effects of intramuscular aripiprazole in the treatment of psychosis-induced aggression or agitation (rapid tranquillisation)." | 8.98 | Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). ( Jajawi, S; Jayaram, MB; Ostinelli, EG; Sayal, K; Spyridi, S, 2018) |
| "Haloperidol used alone is recommended to help calm situations of aggression or agitation for people with psychosis." | 8.95 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Brooke-Powney, MJ; Li, X; Ostinelli, EG, 2017) |
| "To examine whether haloperidol plus promethazine is an effective treatment for psychosis-induced aggression." | 8.93 | Haloperidol plus promethazine for psychosis-induced aggression. ( Alexander, J; Allen, MH; Gandhi, P; Huf, G, 2016) |
| "To examine whether haloperidol alone, administered orally, intramuscularly or intravenously, is an effective treatment for long-term/persistent aggression in psychosis." | 8.93 | Haloperidol for long-term aggression in psychosis. ( Khushu, A; Powney, MJ, 2016) |
| "To estimate the clinical effects of zuclopenthixol acetate for the management of acute aggression or violence thought to be due to serious mental illnesses, in comparison to other drugs used to treat similar conditions." | 8.88 | Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. ( Gibson, RC; Gunadasa, S; Jayakody, K; Kumar, A, 2012) |
| "Haloperidol, used alone is recommended to help calm situations of aggression with people with psychosis." | 8.88 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Jones, H; Powney, MJ, 2012) |
| "To examine the effects of oral or intramuscular chlorpromazine for psychosis induced agitation or aggression." | 8.86 | Chlorpromazine for psychosis induced aggression or agitation. ( Adams, CE; Ahmed, U; Jones, H, 2010) |
| "To examine whether haloperidol plus promethazine is an effective treatment for psychosis induced agitation/aggression." | 8.85 | Haloperidol plus promethazine for psychosis-induced aggression. ( Alexander, J; Allen, MH; Huf, G; Raveendran, NS, 2009) |
| "To examine whether haloperidol plus promethazine is an effective treatment for psychosis induced agitation/aggression." | 8.82 | Haloperidol plus promethazine for psychosis induced aggression. ( Alexander, J; Allen, MH; Huf, G, 2005) |
| " Evidence suggests that haloperidol was useful in the control of aggression, but was associated with increased side effects; there was no evidence to support the routine use of this drug for other manifestations of agitated dementia." | 8.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2002) |
| "The CDCIG Specialized Register was searched to identify all available reports on haloperidol treatment of agitated dementia." | 8.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2001) |
| "A ten year old boy developed features of Tourette syndrome while taking haloperidol for behaviour problems." | 7.68 | A case of Tourette syndrome developing during haloperidol treatment. ( Karagianis, JL; Nagpurkar, R, 1990) |
| "The extracellular levels of dopamine (DA) and its metabolites in the septum of freely moving rats were studied using "push-pull" method during muricidal aggression before and after haloperidol (2 mg/kg, i." | 7.68 | [Effects of haloperidol on extracellular contents of dopamine and its metabolites in the septum of rats during interspecies aggression]. ( Gaĭnetdinov, RR; Gromov, AI; Kudrin, VS; Pletnikov, MS, 1992) |
| "Affective apomorphine-induced aggression was induced in originally nonaggressive rats after withdrawal from prolonged ethanol or haloperidol treatment." | 7.68 | Nicardipine protects against chronic ethanol- or haloperidol-induced supersensitivity to apomorphine-induced aggression. ( Eichelman, B; Pucilowski, O, 1991) |
| "Magnesium has been shown to have certain behavioral effects similar to the stimulants cocaine and amphetamine, particularly on mouse resident-intruder aggression." | 7.67 | Magnesium alters the potency of cocaine and haloperidol on mouse aggression. ( Kantak, KM, 1989) |
| "The role of central histaminergic system in foot shock induced aggression was studied in mice." | 7.66 | Evidence for central histaminergic mechanism in foot shock aggression. ( Bhargava, KP; Dhawan, KN; Gulati, A; Gupta, GP; Nath, C, 1982) |
| " Using an optimizing dosage regime, the outcome variables studied were aggression frequency and the number and nature of emergent side effects." | 6.67 | Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. ( Ancill, RJ; Carlyle, W; Sheldon, L, 1993) |
| "When droperidol was compared with placebo, for the outcome of tranquillisation or asleep by 30 minutes we found evidence of a clear difference (1 RCT, N = 227, RR 1." | 6.53 | Droperidol for psychosis-induced aggression or agitation. ( Khokhar, MA; Rathbone, J, 2016) |
| " droperidol for patients with agitation and aggression." | 5.20 | Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial. ( Calver, L; Drinkwater, V; Gupta, R; Isbister, GK; Page, CB, 2015) |
| "Our results are consistent with those of a similar post-hoc analysis of hostility in first-episode subjects with schizophrenia enrolled in the European First-Episode Schizophrenia Trial (EUFEST) trial, where olanzapine demonstrated advantages compared with haloperidol, quetiapine, and amisulpride." | 5.19 | Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. ( Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J, 2014) |
| "Physically aggressive inpatients with schizophrenia who received an evaluation of depression and impulsivity at baseline were randomly assigned in a double-blind, parallel group, 12-week trial to clozapine, olanzapine, or haloperidol." | 5.19 | Depression and impulsivity as pathways to violence: implications for antiaggressive treatment. ( Czobor, P; Krakowski, MI, 2014) |
| "Ninety-nine physically aggressive inpatients (aged 18-60 years) with schizophrenia or schizoaffective disorder (diagnosed according to DSM-IV) who completed tests of executive function were randomly assigned in a double-blind, parallel-group, 12-week trial to clozapine (n = 32), olanzapine (n = 32), or haloperidol (n = 35)." | 5.16 | Executive function predicts response to antiaggression treatment in schizophrenia: a randomized controlled trial. ( Czobor, P; Krakowski, MI, 2012) |
| "All medications produced a calming effect within one hour of administration, but only olanzapine and haloperidol reduced agitation by less than 10 points, and only olanzapine reduced aggression by less than four points in the first hour." | 5.15 | Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone. ( Baldaçara, L; Cordeiro, DC; Jackoswski, AP; Sanches, M, 2011) |
| "To compare the effects of haloperidol, amisulpride, olanzapine, quetiapine, and ziprasidone on hostility in first-episode schizophrenia, schizoaffective disorder, or schizophreniform disorder." | 5.15 | Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). ( Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J, 2011) |
| " The goal of this study was to assess the effects of clozapine and olanzapine in comparison to the first-generation agent haloperidol on these metabolic parameters in aggressive patients with schizophrenia." | 5.14 | Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. ( Citrome, L; Czobor, P; Krakowski, M, 2009) |
| " Aggression decreased substantially with all three treatments by 4 weeks, with the placebo group showing the greatest change (median decrease in MOAS score after 4 weeks=9 [95% CI 5-14] for placebo, 79% from baseline; 7 [4-14] for risperidone, 58% from baseline; 6." | 5.13 | Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. ( Ahmed, Z; Bhaumik, S; Bouras, N; Cooray, S; Crawford, M; Deb, S; Eliahoo, J; Hare, M; Harley, D; Karatela, S; Kramo, K; Meade, M; Murphy, D; North, B; Oliver-Africano, PC; Rao, B; Reece, B; Regan, A; Soni, A; Thomas, D; Tyrer, P, 2008) |
| "The purpose of this study was to compare the effects of olanzapine, clozapine, and haloperidol on neurocognitive function in schizophrenic patients who present with documented episodes of physical aggression and to determine whether change in cognitive function is related to aggression." | 5.13 | Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. ( Czobor, P; Krakowski, MI; Nolan, KA, 2008) |
| "Clozapine was superior to both olanzapine and haloperidol in reducing the number and severity of physical assaults as assessed by the MOAS physical aggression score and in reducing overall aggression as measured by the MOAS total score." | 5.12 | Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. ( Bark, N; Citrome, L; Cooper, TB; Czobor, P; Krakowski, MI, 2006) |
| "The goal of this study was to compare the efficacy and safety of olanzapine versus haloperidol in the treatment of agitation and aggression in patients with dementia." | 5.12 | Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial. ( Lousberg, R; Verhey, FR; Verkaaik, M, 2006) |
| "As monotherapy, both olanzapine and risperidone were superior to haloperidol and clozapine in reducing aggression." | 5.11 | Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO). ( Bitter, I; Czobor, P; Dossenbach, M; Volavka, J, 2005) |
| " Midazolam was more rapidly sedating than haloperidol-promethazine, reducing the time people are exposed to aggression." | 5.10 | Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. ( , 2003) |
| "44 patients with chronic DSM-IV schizophrenia were treated with clozapine or haloperidol decanoate in an open prospective 6-month trial." | 5.10 | The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. ( Mester, R; Shabash, E; Sheitman, B; Spivak, B; Weizman, A, 2003) |
| "For the 60 patients who completed phase A, standard-dose haloperidol was efficacious and superior to both low-dose haloperidol and placebo for scores on the Brief Psychiatric Rating Scale psychosis factor and on psychomotor agitation." | 5.08 | A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. ( Bell, K; Cooper, TB; Devanand, DP; Marder, K; Mayeux, R; Michaels, KS; Pelton, GH; Sackeim, HA; Sullivan, MA, 1998) |
| "In a double-blind, prospective study, 2 mg of intramuscular lorazepam and 5 mg of intramuscular haloperidol were equally effective in controlling aggression, agitation, and assaultive behavior." | 5.07 | Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. ( Flowers, E; Glassman, R; Miyawaki, E; Rood, L; Salzman, C; Solomon, D; Thayer, S, 1991) |
| "We now present data from a randomized, double-blind clinical study of lorazepam versus haloperidol in 20 hospitalized patients with a DSM-III-R diagnosis of bipolar disorder who were being treated concomitantly with lithium." | 5.07 | Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. ( Creelman, WL; Lenox, RH; Newhouse, PA; Whitaker, TM, 1992) |
| " Haloperidol has a relatively weak effect on aggression when given alone and can also cause side effects such as early dyskinesia and epileptic seizures." | 5.01 | The Use of Rapid Tranquilization in Aggressive Behavior. ( Hirsch, S; Steinert, T, 2019) |
| "To evaluate the effects of intramuscular aripiprazole in the treatment of psychosis-induced aggression or agitation (rapid tranquillisation)." | 4.98 | Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). ( Jajawi, S; Jayaram, MB; Ostinelli, EG; Sayal, K; Spyridi, S, 2018) |
| "Haloperidol used alone is recommended to help calm situations of aggression or agitation for people with psychosis." | 4.95 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Brooke-Powney, MJ; Li, X; Ostinelli, EG, 2017) |
| "To examine whether haloperidol plus promethazine is an effective treatment for psychosis-induced aggression." | 4.93 | Haloperidol plus promethazine for psychosis-induced aggression. ( Alexander, J; Allen, MH; Gandhi, P; Huf, G, 2016) |
| "To examine whether haloperidol alone, administered orally, intramuscularly or intravenously, is an effective treatment for long-term/persistent aggression in psychosis." | 4.93 | Haloperidol for long-term aggression in psychosis. ( Khushu, A; Powney, MJ, 2016) |
| "Haloperidol, used alone is recommended to help calm situations of aggression with people with psychosis." | 4.88 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Jones, H; Powney, MJ, 2012) |
| "To estimate the clinical effects of zuclopenthixol acetate for the management of acute aggression or violence thought to be due to serious mental illnesses, in comparison to other drugs used to treat similar conditions." | 4.88 | Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. ( Gibson, RC; Gunadasa, S; Jayakody, K; Kumar, A, 2012) |
| "Haloperidol in combination with promethazine, and olanzapine, are effective in psychotic agitation, although haloperidol plus promethazine has a more rapid onset of effect faster; lorazepam is effective in non-psychotic agitation, aggression or excitement as well as in acute agitation of unknown origin." | 4.87 | [Rapid tranquillisation; review of the literature and recommendations]. ( Bak, M; Marcelis, M; van Os, J, 2011) |
| "To examine the effects of oral or intramuscular chlorpromazine for psychosis induced agitation or aggression." | 4.86 | Chlorpromazine for psychosis induced aggression or agitation. ( Adams, CE; Ahmed, U; Jones, H, 2010) |
| "To examine whether haloperidol plus promethazine is an effective treatment for psychosis induced agitation/aggression." | 4.85 | Haloperidol plus promethazine for psychosis-induced aggression. ( Alexander, J; Allen, MH; Huf, G; Raveendran, NS, 2009) |
| "To examine whether haloperidol plus promethazine is an effective treatment for psychosis induced agitation/aggression." | 4.82 | Haloperidol plus promethazine for psychosis induced aggression. ( Alexander, J; Allen, MH; Huf, G, 2005) |
| " Evidence suggests that haloperidol was useful in the control of aggression, but was associated with increased side effects; there was no evidence to support the routine use of this drug for other manifestations of agitated dementia." | 4.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2002) |
| "The CDCIG Specialized Register was searched to identify all available reports on haloperidol treatment of agitated dementia." | 4.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2001) |
| "Lithium carbonate is the single most important long-term treatment for recurrent affective disorders." | 4.76 | Lithium. ( DePaulo, JR, 1984) |
| "A 60-year-old man with rapidly progressive frontotemporal dementia complicated by severe aggression was managed in specialised psychogeriatric services and high-dose haloperidol was used." | 3.80 | Managing severe aggression in frontotemporal dementia. ( Flynn, P; McKellar, D; Powell, A; Rischbieth, S, 2014) |
| "Zuclopenthixol also has the advantage for both patients and nursing staff that dosage is once daily." | 3.77 | Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway. ( Elgen, K; Fuglum, E; Nygaard, HA, 1992) |
| "The behavioral effects of eltoprazine and haloperidol during a 4 week treatment period were studied in the resident-intruder model of aggression in male rats." | 3.69 | Chronic treatment with eltoprazine does not lead to tolerance in its anti-aggressive action, in contrast to haloperidol. ( Mos, J; Olivier, B; van Aken, HH; van Oorschot, R, 1996) |
| " The anticonvulsant effect of caerulein (125 micrograms/kg) against picrotoxin (10 mg/kg) induced seizures was abolished after 14 days diazepam, but not after haloperidol, treatment." | 3.68 | Changes at cholecystokinin receptors induced by long-term treatment with diazepam and haloperidol. ( Harro, J; Lang, A; Soosaar, A; Vasar, E, 1992) |
| "The extracellular levels of dopamine (DA) and its metabolites in the septum of freely moving rats were studied using "push-pull" method during muricidal aggression before and after haloperidol (2 mg/kg, i." | 3.68 | [Effects of haloperidol on extracellular contents of dopamine and its metabolites in the septum of rats during interspecies aggression]. ( Gaĭnetdinov, RR; Gromov, AI; Kudrin, VS; Pletnikov, MS, 1992) |
| "After cessation of long-term treatment with haloperidol, a 77-year-old man developed severe dyskinetic-dystonic movements involving mainly the tongue and associated also with oromandibular dystonia and blepharospasm that were manifested exclusively during the process of eating and that interfered with feeding." | 3.68 | Tardive eating dystonia. ( Achiron, A; Melamed, E, 1990) |
| "A ten year old boy developed features of Tourette syndrome while taking haloperidol for behaviour problems." | 3.68 | A case of Tourette syndrome developing during haloperidol treatment. ( Karagianis, JL; Nagpurkar, R, 1990) |
| "Magnesium has been shown to have certain behavioral effects similar to the stimulants cocaine and amphetamine, particularly on mouse resident-intruder aggression." | 3.67 | Magnesium alters the potency of cocaine and haloperidol on mouse aggression. ( Kantak, KM, 1989) |
| " Pretreatment with flupentixol and haloperidol inhibited or blocked CLO-evoked aggression in high-aggressive mice." | 3.67 | [Clopheline-induced aggression in mice: role of genotype and the dopaminergic system]. ( Klimek, V; Nikulina, EM; Popova, NK, 1989) |
| " Adjunctive treatment with clonazepam resulted in the cessation of the seizures and of persistent, violent hallucinations." | 3.67 | Antiaggressive effect of adjunctive clonazepam in schizophrenia associated with seizure disorder. ( Keats, MM; Mukherjee, S, 1988) |
| " The drug does not possess an antidepressant action proper but activates the aggressive-defensive behaviour in experimental reserpine depression and reduces the provocation-induced aggressive behaviour in experimental haloperidol depression." | 3.66 | [Psychopharmacologic spectrum of melanostatin]. ( Klusha, VE; Kozlovskaia, MM; Svirskis, ShV; Val'dman, AV, 1980) |
| "The role of central histaminergic system in foot shock induced aggression was studied in mice." | 3.66 | Evidence for central histaminergic mechanism in foot shock aggression. ( Bhargava, KP; Dhawan, KN; Gulati, A; Gupta, GP; Nath, C, 1982) |
| " An even stronger effect on the emotional and in addition on the reaction of aggression is produced by haloperidol." | 3.65 | [The influence of neuroleptics on the emotional anger reaction in animals]. ( Burow, W, 1975) |
| " Using an optimizing dosage regime, the outcome variables studied were aggression frequency and the number and nature of emergent side effects." | 2.67 | Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. ( Ancill, RJ; Carlyle, W; Sheldon, L, 1993) |
| " Dosage ratios of loxapine to haloperidol ranged from a minimum of 2." | 2.66 | A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients. ( Tuason, VB, 1986) |
| "When droperidol was compared with placebo, for the outcome of tranquillisation or asleep by 30 minutes we found evidence of a clear difference (1 RCT, N = 227, RR 1." | 2.53 | Droperidol for psychosis-induced aggression or agitation. ( Khokhar, MA; Rathbone, J, 2016) |
| "Challenging behaviour in patients with intellectual disability may be caused by physical, psychological and environmental factors." | 2.50 | [Challenging behaviour in patients with intellectual disability]. ( de Kuijper, GM; Vrijmoeth, P, 2014) |
| " Renal dosing for topiramate, reduction in PIMs/anticholinergic burden, and substituting haloperidol for olanzapine resolved his violent behavior and CD." | 2.50 | Capgras delusion with violent behavior in Alzheimer dementia: case analysis with literature review. ( Dawood, A; Kaufman, KR; Newman, NB, 2014) |
| "When haloperidol and midazolam were compared with olanzapine, there was some evidence the combination was superior in terms of improvement, sedation and behaviour." | 2.49 | Benzodiazepines for psychosis-induced aggression or agitation. ( Beck, A; Gillies, D; Rathbone, J; Sampson, S, 2013) |
| "Triadimefon (TDF) is a triazole fungicide extensively used in agriculture that has been found as a pollutant in numerous water sources." | 1.51 | Behavioral effects of triadimefon in zebrafish are associated with alterations of the dopaminergic and serotonergic pathways. ( Alcayaga, J; Allende, ML; De la Paz, JF; Paredes-Zúñiga, S; Trost, N, 2019) |
| "Bilateral intraocular pressures were monitored before and after the first 7 ECTs and intermittently after ECT for 10 months of maintenance ECT." | 1.40 | Stability of intraocular pressure after retinal reattachment surgery during electroconvulsive therapy for intractable self-injury in a 12-year-old autistic boy. ( Reti, IM; Wachtel, LE; Ying, H, 2014) |
| " These data indicate that chronic administration of RISP and HAL impede behavioral recovery after TBI and impair performance in uninjured controls." | 1.35 | Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury. ( Cheng, JP; Hoffman, AN; Kline, AE; Massucci, JL; Zafonte, RD, 2008) |
| " In addition, adverse events were also evaluated." | 1.34 | [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. ( Agoston, T; István, S; Tamás, T; Zoltán, J, 2007) |
| "Apomorphine was found to disrupt memory consolidation in a dose-dependent manner on chicks trained on a 1-trial passive avoidance task with a strong aversant experience." | 1.31 | The effects of apomorphine and haloperidol on memory consolidation in the day-old chick. ( Crowe, SF; Hale, MW, 2001) |
| "Pretreatment with haloperidol suppressed both the antiparkinsonian effects and the hyperactivity induced by apomorphine." | 1.29 | Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys. ( Akai, T; Kuno, S; Mizuta, E; Yamaguchi, M, 1993) |
| " No change in fighting or Bmax was observed with the chronic administration of d-propranolol (5 mg/kg bid) or metoprolol (10 mg/kg bid)." | 1.27 | Increased shock-induced fighting with supersensitive beta-adrenergic receptors. ( Eichelman, B; Hegstrand, LR, 1983) |
| "3) Amantadine was equipotent to imipramine in suppressing haloperidol-induced catalepsy in rats, but L-DOPA was without effect." | 1.27 | [Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats]. ( Fujiwara, M; Kiyota, Y; Ohta, H; Sakurai, Y; Shibata, S; Shimazoe, T; Ueki, S, 1985) |
| "Unlike apomorphine, Ro 15-1788 reversed catalepsy induced by haloperidol (0." | 1.27 | [Effect of an imidazobenzodiazepine (RO 15-1788) on aggressive behavior in mice]. ( Allikmets, LKh; Maĭmets, MO; Nurk, AM; Riago, LK; Vasar, EE, 1984) |
| "The pharmacokinetic behaviour of haloperidol (0." | 1.27 | Pharmacokinetics and effects of haloperidol in the isolated mouse. ( Baumann, GH; Zetler, G, 1985) |
| "Pretreatment with haloperidol (1 mg/kg) partially blocked the PCP-induced hyperactivity but pretreatment with methysergide (3 mg/kg) did not." | 1.26 | Effects of phencyclidine on aggressive behavior in mice. ( Miczek, KA; Tyler, CB, 1982) |
| "Maprotiline was more potent than anitriptyline and imipramine in antagonizing haloperidol-induced catalepsy as well as in suppressing muricide induced by either olfactory bulbectomy or delta-9-tetrahydrocannabinol in rats." | 1.25 | [Behavior pharmacology of maprotiline, a new antidepressant]. ( Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 85 (44.27) | 18.7374 |
| 1990's | 37 (19.27) | 18.2507 |
| 2000's | 36 (18.75) | 29.6817 |
| 2010's | 32 (16.67) | 24.3611 |
| 2020's | 2 (1.04) | 2.80 |
| Authors | Studies |
|---|---|
| Hirsch, S | 1 |
| Steinert, T | 1 |
| Khoodoruth, MAS | 1 |
| Khan, AA | 1 |
| Faay, MDM | 1 |
| Sommer, IE | 1 |
| Jürgens, G | 1 |
| Bauer, JØ | 1 |
| Ostinelli, EG | 2 |
| Brooke-Powney, MJ | 1 |
| Li, X | 1 |
| Adams, CE | 5 |
| Jajawi, S | 1 |
| Spyridi, S | 1 |
| Sayal, K | 1 |
| Jayaram, MB | 1 |
| Paredes-Zúñiga, S | 1 |
| Trost, N | 1 |
| De la Paz, JF | 1 |
| Alcayaga, J | 1 |
| Allende, ML | 1 |
| Bak, M | 2 |
| Weltens, I | 1 |
| Bervoets, C | 1 |
| De Fruyt, J | 1 |
| Samochowiec, J | 1 |
| Fiorillo, A | 1 |
| Sampogna, G | 1 |
| Bienkowski, P | 1 |
| Preuss, WU | 1 |
| Misiak, B | 1 |
| Frydecka, D | 1 |
| Samochowiec, A | 1 |
| Bak, E | 1 |
| Drukker, M | 1 |
| Dom, G | 1 |
| Gillies, D | 1 |
| Sampson, S | 1 |
| Beck, A | 1 |
| Rathbone, J | 2 |
| Wachtel, LE | 1 |
| Reti, IM | 1 |
| Ying, H | 1 |
| Krakowski, MI | 5 |
| Czobor, P | 10 |
| Powell, A | 1 |
| Flynn, P | 1 |
| Rischbieth, S | 1 |
| McKellar, D | 1 |
| Chandler, A | 1 |
| Freeze-Ramsey, R | 1 |
| Seupaul, RA | 1 |
| Volavka, J | 4 |
| Citrome, L | 4 |
| Van Dorn, RA | 1 |
| Kaufman, KR | 1 |
| Newman, NB | 1 |
| Dawood, A | 1 |
| Calver, L | 1 |
| Drinkwater, V | 1 |
| Gupta, R | 1 |
| Page, CB | 1 |
| Isbister, GK | 1 |
| de Kuijper, GM | 1 |
| Vrijmoeth, P | 1 |
| Cheĭdo, MA | 1 |
| Idova, GV | 1 |
| Fragoso, VM | 1 |
| Hoppe, LY | 1 |
| de Araújo-Jorge, TC | 1 |
| de Azevedo, MJ | 1 |
| Campos, JD | 1 |
| Cortez, CM | 1 |
| de Oliveira, GM | 1 |
| Huf, G | 5 |
| Alexander, J | 3 |
| Gandhi, P | 1 |
| Allen, MH | 3 |
| Khushu, A | 1 |
| Powney, MJ | 2 |
| Khokhar, MA | 1 |
| Nolan, KA | 1 |
| Kline, AE | 1 |
| Hoffman, AN | 1 |
| Cheng, JP | 1 |
| Zafonte, RD | 1 |
| Massucci, JL | 1 |
| San, L | 1 |
| Sekiguchi, K | 1 |
| Yamaguchi, T | 1 |
| Tabuchi, M | 1 |
| Ikarashi, Y | 1 |
| Kase, Y | 1 |
| Krakowski, M | 1 |
| Tyrer, P | 4 |
| Oliver-Africano, P | 3 |
| Romeo, R | 2 |
| Knapp, M | 3 |
| Dickens, S | 2 |
| Bouras, N | 3 |
| Ahmed, Z | 3 |
| Cooray, S | 3 |
| Deb, S | 3 |
| Murphy, D | 2 |
| Hare, M | 3 |
| Meade, M | 3 |
| Reece, B | 3 |
| Kramo, K | 2 |
| Bhaumik, S | 3 |
| Harley, D | 3 |
| Regan, A | 3 |
| Thomas, D | 2 |
| Rao, B | 3 |
| Karatela, S | 3 |
| Lenôtre, L | 2 |
| Watson, J | 2 |
| Soni, A | 2 |
| Crawford, M | 3 |
| Eliahoo, J | 2 |
| North, B | 2 |
| Raveendran, NS | 1 |
| Piachaud, J | 1 |
| Ade Thomas, D | 1 |
| Dzendrowskyj, T | 1 |
| Birmingham, C | 1 |
| Ban, K | 1 |
| Rosen, P | 1 |
| Wolfe, R | 1 |
| Davis, D | 1 |
| Sakles, J | 1 |
| Bramwell, K | 1 |
| Sanchez, LD | 1 |
| Ahmed, U | 1 |
| Jones, H | 2 |
| Baldaçara, L | 1 |
| Sanches, M | 1 |
| Cordeiro, DC | 1 |
| Jackoswski, AP | 1 |
| Derks, EM | 1 |
| Bitter, I | 2 |
| Libiger, J | 1 |
| Kahn, RS | 1 |
| Fleischhacker, WW | 1 |
| Makkos, Z | 1 |
| Fejes, L | 1 |
| Inczédy-Farkas, G | 1 |
| Kassai-Farkas, A | 1 |
| Faludi, G | 1 |
| Lazáry, J | 1 |
| van Os, J | 1 |
| Marcelis, M | 1 |
| Jayakody, K | 1 |
| Gibson, RC | 1 |
| Kumar, A | 1 |
| Gunadasa, S | 1 |
| Georgieva, I | 1 |
| Mulder, CL | 1 |
| Noorthoorn, E | 1 |
| Spivak, B | 1 |
| Shabash, E | 1 |
| Sheitman, B | 2 |
| Weizman, A | 2 |
| Mester, R | 1 |
| HAWARD, LR | 1 |
| Coffey, B | 1 |
| Espinosa-Avilés, D | 1 |
| Elizondo, G | 1 |
| Morales-Martínez, M | 1 |
| Rodríguez-Herrejón, F | 1 |
| Varela, P | 1 |
| Nolan, K | 1 |
| Lindenmayer, JP | 1 |
| McEvoy, JP | 1 |
| Cooper, TB | 3 |
| Lieberman, JA | 1 |
| Finch, S | 1 |
| Belgamwar, RB | 1 |
| Fenton, M | 1 |
| Dossenbach, M | 1 |
| Verhey, FR | 2 |
| Verkaaik, M | 1 |
| Lousberg, R | 1 |
| Bark, N | 1 |
| Zuidema, SU | 1 |
| van Iersel, MB | 1 |
| Koopmans, RT | 1 |
| Olde Rikkert, MG | 1 |
| Villari, V | 1 |
| Rocca, P | 1 |
| Fonzo, V | 1 |
| Montemagni, C | 1 |
| Pandullo, P | 1 |
| Bogetto, F | 1 |
| Coutinho, ES | 1 |
| Matson, JL | 1 |
| Wilkins, J | 1 |
| Oliver-Africano, PC | 1 |
| Demily, C | 1 |
| Franck, N | 1 |
| István, S | 1 |
| Agoston, T | 1 |
| Tamás, T | 1 |
| Zoltán, J | 1 |
| Val'dman, AV | 1 |
| Kozlovskaia, MM | 1 |
| Klusha, VE | 1 |
| Svirskis, ShV | 1 |
| Tufik, S | 1 |
| Kinze, W | 1 |
| Conn, LM | 1 |
| Lion, JR | 1 |
| Vasar, EE | 1 |
| Maĭmets, MO | 1 |
| Riago, LK | 1 |
| Nurk, AM | 1 |
| Allikmets, LKh | 2 |
| Hegstrand, LR | 1 |
| Eichelman, B | 3 |
| Bennett, WG | 2 |
| Korein, J | 1 |
| Kalmijn, M | 1 |
| Grega, DM | 3 |
| Campbell, M | 7 |
| DePaulo, JR | 1 |
| Miczek, KA | 2 |
| DeBold, JF | 1 |
| Thompson, ML | 1 |
| Baggio, G | 3 |
| Ferrari, F | 3 |
| Small, AM | 1 |
| Green, WH | 4 |
| Jennings, SJ | 1 |
| Perry, R | 2 |
| Anderson, L | 1 |
| Platt, JE | 4 |
| Beatty, WW | 1 |
| Costello, KB | 1 |
| Berry, SL | 1 |
| Yoshimura, H | 1 |
| Ogawa, N | 1 |
| De Feo, G | 1 |
| Lisciani, R | 1 |
| Pavan, L | 1 |
| Samarelli, M | 1 |
| Valeri, P | 1 |
| Cohen, IL | 2 |
| Nath, C | 1 |
| Gulati, A | 1 |
| Dhawan, KN | 1 |
| Gupta, GP | 1 |
| Bhargava, KP | 1 |
| Fialkov, MJ | 1 |
| Sonis, WA | 1 |
| Rapport, MD | 1 |
| Kazdin, AE | 1 |
| Tyler, CB | 1 |
| Pellis, SM | 1 |
| McKenna, M | 1 |
| Lang, A | 2 |
| Harro, J | 2 |
| Soosaar, A | 2 |
| Kõks, S | 1 |
| Volke, V | 1 |
| Oreland, L | 1 |
| Bourin, M | 1 |
| Vasar, E | 2 |
| Bradwejn, J | 1 |
| Männistö, PT | 1 |
| Akai, T | 1 |
| Yamaguchi, M | 1 |
| Mizuta, E | 1 |
| Kuno, S | 1 |
| Steinpreis, RE | 1 |
| Sokolowski, JD | 1 |
| Papanikolaou, A | 1 |
| Salamone, JD | 1 |
| Brock, G | 1 |
| Gurekas, VL | 1 |
| Thomas, JE | 1 |
| Carlyle, W | 1 |
| Ancill, RJ | 1 |
| Sheldon, L | 1 |
| Navarro, JF | 1 |
| Miñarro, J | 3 |
| Simón, VM | 2 |
| Mos, J | 1 |
| van Aken, HH | 1 |
| van Oorschot, R | 1 |
| Olivier, B | 1 |
| Kafantaris, V | 1 |
| Lee, DO | 1 |
| Magee, H | 1 |
| Winny, G | 1 |
| Samuel, R | 1 |
| Pollack, S | 1 |
| Sakamoto, H | 1 |
| Matsumoto, K | 1 |
| Ohno, Y | 1 |
| Nakamura, M | 1 |
| Devanand, DP | 1 |
| Marder, K | 1 |
| Michaels, KS | 1 |
| Sackeim, HA | 1 |
| Bell, K | 1 |
| Sullivan, MA | 1 |
| Pelton, GH | 1 |
| Mayeux, R | 1 |
| Dorevitch, A | 1 |
| Katz, N | 1 |
| Zemishlany, Z | 1 |
| Aizenberg, D | 1 |
| Millan, MJ | 2 |
| Brocco, M | 2 |
| Gobert, A | 1 |
| Schreiber, R | 1 |
| Dekeyne, A | 2 |
| Palit, G | 1 |
| Kumar, R | 1 |
| Gupta, MB | 1 |
| Saxena, RC | 1 |
| Patnaik, GK | 1 |
| Dhawan, BN | 1 |
| Singh, Y | 1 |
| Jaiswal, AK | 1 |
| Singh, M | 1 |
| Bhattacharya, SK | 1 |
| Kudryavtseva, NN | 1 |
| Lipina, TV | 1 |
| Koryakina, LA | 1 |
| Hughes, DH | 1 |
| Rodríguez-Arias, M | 1 |
| Pinazo, J | 1 |
| Stinus, L | 1 |
| Rivet, JM | 1 |
| Audinot, V | 1 |
| Newman-Tancredi, A | 1 |
| Maiofiss, L | 1 |
| Queriaux, S | 1 |
| Despaux, N | 1 |
| Peglion, JL | 1 |
| Allain, H | 1 |
| Dautzenberg, PH | 1 |
| Maurer, K | 1 |
| Schuck, S | 1 |
| Bonhomme, D | 1 |
| Gérard, D | 1 |
| Skrebuhhova-Malmros, T | 1 |
| Pruus, K | 1 |
| Rudissaar, R | 1 |
| Allikmets, L | 1 |
| Matto, V | 1 |
| Currier, GW | 1 |
| Hale, MW | 1 |
| Crowe, SF | 1 |
| Pfitzer, S | 1 |
| Lambrechts, H | 1 |
| Lonergan, E | 2 |
| Luxenberg, J | 2 |
| Colford, J | 2 |
| da Silva Freire Coutinho, E | 1 |
| Fagundes, HM | 1 |
| Oliveira, ES | 1 |
| Lopez, JR | 1 |
| Gewandszajder, M | 1 |
| da Luz Carvalho, A | 1 |
| Keusen, A | 1 |
| Winsberg, BG | 1 |
| Yepes, LE | 1 |
| Bialer, I | 1 |
| Paprocki, J | 1 |
| Versiani, M | 1 |
| Albert, DJ | 1 |
| Richmond, SE | 1 |
| Dunne, M | 1 |
| Hine, B | 1 |
| Wallach, MB | 1 |
| Gershon, S | 2 |
| Lal, H | 3 |
| Gianutsos, G | 2 |
| Puri, SK | 1 |
| Fruensgaard, K | 1 |
| Korsgaard, S | 1 |
| Jorgensen, H | 1 |
| Jensen, K | 1 |
| Nadel, I | 1 |
| Wallach, M | 1 |
| Allikmets, LH | 1 |
| Stanley, M | 1 |
| Arnt, J | 1 |
| Scheel-Krüger, J | 1 |
| Burow, W | 1 |
| Werry, JS | 1 |
| Aman, MG | 1 |
| Sheinbein, ML | 1 |
| Wiggins, KM | 1 |
| Ueki, S | 2 |
| Fujiwara, M | 2 |
| Inoue, K | 1 |
| Kataoka, Y | 1 |
| Ibii, N | 1 |
| Burov, IuV | 2 |
| Salimov, RM | 1 |
| Nygaard, HA | 1 |
| Fuglum, E | 2 |
| Elgen, K | 2 |
| Cook, L | 1 |
| Tam, SW | 1 |
| Rohrbach, KW | 1 |
| Junaid, O | 1 |
| Langenbach, M | 1 |
| Ruiz, P | 1 |
| Hodgson, C | 1 |
| Kennedy, J | 1 |
| Moorhead, S | 1 |
| Tu, JB | 1 |
| Hartridge, C | 1 |
| Izawa, J | 1 |
| Gaĭnetdinov, RR | 1 |
| Gromov, AI | 1 |
| Kudrin, VS | 1 |
| Pletnikov, MS | 1 |
| Lenox, RH | 1 |
| Newhouse, PA | 1 |
| Creelman, WL | 1 |
| Whitaker, TM | 1 |
| Thomas, H | 1 |
| Schwartz, E | 1 |
| Petrilli, R | 1 |
| Salzman, C | 2 |
| Solomon, D | 1 |
| Miyawaki, E | 1 |
| Glassman, R | 1 |
| Rood, L | 1 |
| Flowers, E | 1 |
| Thayer, S | 1 |
| Becker, A | 1 |
| Ruethrich, HL | 1 |
| Schneider, R | 1 |
| Grecksch, G | 1 |
| Matthies, H | 1 |
| Sweidan, S | 1 |
| Edinger, H | 1 |
| Siegel, A | 1 |
| White, SM | 1 |
| Kucharik, RF | 1 |
| Moyer, JA | 1 |
| Wong, SE | 1 |
| Floyd, J | 1 |
| Innocent, AJ | 1 |
| Woolsey, JE | 1 |
| Pucilowski, O | 2 |
| Wasielewski, S | 1 |
| Yudofsky, SC | 1 |
| Silver, JM | 1 |
| Hales, RE | 1 |
| Achiron, A | 1 |
| Melamed, E | 1 |
| Castaño, D | 1 |
| Brain, PF | 1 |
| Karagianis, JL | 1 |
| Nagpurkar, R | 1 |
| Kantak, KM | 1 |
| Nikulina, EM | 1 |
| Klimek, V | 1 |
| Popova, NK | 1 |
| Schillinger, A | 1 |
| Andersen, JB | 1 |
| Belstad, BE | 1 |
| Jensen, D | 1 |
| Müller, F | 1 |
| Müller, KJ | 1 |
| Schulstad, B | 1 |
| Lande, RG | 1 |
| Päivärinta, P | 1 |
| Korpi, ER | 1 |
| Fujiwara, Y | 1 |
| Takeda, T | 1 |
| Kazahaya, Y | 1 |
| Otsuki, S | 1 |
| Sandyk, R | 1 |
| Francesca, F | 1 |
| Ruhland, M | 1 |
| Liepmann, H | 1 |
| Muesch, HR | 1 |
| Stewart, JT | 1 |
| Mounts, ML | 1 |
| Clark, RL | 1 |
| Bruun, RD | 1 |
| Holloway, WR | 1 |
| Thor, DH | 1 |
| Sakurai, Y | 1 |
| Kiyota, Y | 1 |
| Shimazoe, T | 1 |
| Ohta, H | 1 |
| Shibata, S | 1 |
| Maeda, H | 2 |
| Maki, S | 2 |
| Uchimura, H | 1 |
| Kostowski, W | 2 |
| Keats, MM | 1 |
| Mukherjee, S | 1 |
| Widlöcher, D | 1 |
| Tuason, VB | 1 |
| Soloff, PH | 1 |
| George, A | 1 |
| Nathan, RS | 1 |
| Schulz, PM | 1 |
| Perel, JM | 1 |
| Tampieri, A | 1 |
| Mangiafico, V | 1 |
| Poli, A | 1 |
| Palermo-Neto, J | 1 |
| Cohen-Mansfield, J | 1 |
| Zetler, G | 2 |
| Baumann, GH | 2 |
| Fishbain, DA | 1 |
| Schiffman, J | 1 |
| Sato, T | 1 |
| Nakao, K | 1 |
| Higashio, T | 1 |
| Inukai, T | 1 |
| Papeschi, R | 1 |
| Shapiro, AK | 1 |
| Shapiro, E | 1 |
| Boissier, JR | 1 |
| Grasset, S | 1 |
| Simon, P | 1 |
| Puri, S | 1 |
| Czlonkowski, A | 1 |
| Drawbaugh, RB | 1 |
| Hynes, MD | 1 |
| Cunningham, MA | 1 |
| Pillai, V | 1 |
| Rogers, WJ | 1 |
| Barker, P | 1 |
| Fraser, IA | 1 |
| Le Vann, LJ | 1 |
| Vysotskaia, NB | 1 |
| Boĭko, SS | 1 |
| Aleshinkova, TN | 1 |
| Vakhing, VA | 1 |
| Mekhilane, LS | 1 |
| Oldham, AJ | 1 |
| Bott, M | 1 |
| Faretra, G | 1 |
| Dooher, L | 1 |
| Dowling, J | 1 |
| Duncan, RL | 1 |
| Helsley, GC | 1 |
| Welstead, WJ | 1 |
| DaVanzo, JP | 1 |
| Funderburk, WH | 1 |
| Lunsford, CD | 1 |
| Senault, B | 1 |
| Yen, HC | 1 |
| Katz, MH | 1 |
| Krop, S | 1 |
| Lichko, AE | 1 |
| Marchenko, BV | 1 |
| Prakhov, VI | 1 |
| Radavichius, LI | 1 |
| Khaliavin, AV | 1 |
| Gane, P | 1 |
| Stroescu, V | 1 |
| Ciorbaru, R | 1 |
| Granici, A | 1 |
| Gheorghiu, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clozapine and Olanzapine in the Treatment of Violence in Schizophrenic Patients[NCT01123408] | 110 participants (Actual) | Interventional | 1999-06-30 | Completed | |||
| Ketamine Versus Midazolam for Prehospital Agitation[NCT03554915] | 314 participants (Actual) | Observational | 2017-08-01 | Completed | |||
| Treatment of Psychosis and Agitation in Alzheimer's Disease[NCT02129348] | Phase 2 | 77 participants (Actual) | Interventional | 2014-06-30 | Completed | ||
| Elderly Patients With Dementia in the Department of Acute Geriatrics: Pilot Study, Monocentric, Randomized Use of Aromatherapy as a Complementary Treatment to Psychopharmacotherapy in Psychological Disorders and BPSD Behavior[NCT03662360] | 32 participants (Actual) | Interventional | 2018-05-20 | Completed | |||
| Behavior Therapy and Psychosocial Treatment for Tourette Syndrome and Chronic Tic Disorder[NCT00231985] | Phase 2 | 122 participants (Actual) | Interventional | 2005-10-31 | Completed | ||
| Can Virtual Reality Reduce Depression and Agitation in Older Adults With Moderate to Severe Dementia? A Randomized Controlled Trial.[NCT04347668] | 266 participants (Anticipated) | Interventional | 2019-04-01 | Recruiting | |||
| Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia (LDIR-CT-AD) Trial: A Pilot Study[NCT03597360] | 4 participants (Actual) | Interventional | 2019-01-08 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Basic Activities of Daily Living with items for 6 functions: bathing, dressing, toileting, transferring, continence, and feeding. Each item is scored as unimpaired=1, impaired=0. Total score is the measure used, range 0-6; higher scores indicate better functioning. (NCT02129348)
Timeframe: Assessed at Week 0, Week2, Week 4, Week 6, Week 8, Week 10, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | 0.3 |
| Placebo Group | 0.1 |
Neuropsychiatric Inventory (NPI) Agitation/Aggression Domain is the measure used that combines symptoms of agitation and aggression. Frequency X Severity rating score, range 0-12. Higher score indicates more agitation and aggressive behavior. (NCT02129348)
Timeframe: Assessed at screening, Week 0, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | 3.2 |
| Placebo Group | 2.5 |
Clinical Global Impression (CGI) Behavior Change score is the measure used to assess change in overall behavior; scoring range 1-7 with higher scores indicating worsening over time and lower scores indicating improvement over time. Scores ranging from 1-3 indicate improvement. Only patients that demonstrated improvement at week 12 were reported; scores for earlier weeks were only used to assess progress throughout the study. (NCT02129348)
Timeframe: Week 12
| Intervention | Participants (Count of Participants) |
|---|---|
| Lithium Treatment Group | 12 |
| Placebo Group | 8 |
The patient is classified as a responder (score=1) if both criteria are met or as a non-responder (score=0) if both criteria are not met. The first criterion to determine responder status, NPI core score, has a scoring range 0-36; each of the three component scores for symptoms of agitation/aggression, delusions and hallucinations has a scoring range 0-12. For each symptom and the total score, higher score indicates more symptoms. The second criterion to determine responder status, Clinical Global Impression (CGI), is used to assess change in overall behavior; scoring range 1-7 with higher scores indicating worsening over time and lower scores indicating improvement over time. Only patients who met both criteria, assessed as change compared to baseline, were counted as responders; all other patients were non-responders. Patients that demonstrated improvement at week 12 were reported; scores for earlier weeks were only used to assess progress throughout the study. (NCT02129348)
Timeframe: Week 12
| Intervention | Participants (Count of Participants) |
|---|---|
| Lithium Treatment Group | 12 |
| Placebo Group | 7 |
30 item questionnaire used to assess degree of cognitive impairment. Orientation, registration, attention/calculation, recall, language, repetitions and commands are assessed. Total score is the measure used; range 0-30, higher scores indicate better global cognitive function. (NCT02129348)
Timeframe: Assessed at Screening, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | 0.9 |
| Placebo Group | 0.9 |
Neuropsychological test used to assess a patient's cognitive ability. The patient is asked to complete small tasks such as drawing shapes and printing their name. They are also asked to remember certain names and objects, such as a cup and a spoon, and the evaluator's first name. Total score is the measure used; range 0-100, higher scores indicate better cognition. (NCT02129348)
Timeframe: Assessed at Week 0, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | 2.1 |
| Placebo Group | -0.0 |
Simpson Angus Scale for Extrapyramidal Sign requires in-person examination to assess gait, arm dropping, shoulder shaking, elbow rigidity, wrist rigidity, leg pendulousness, head dropping, glabella tap, tremor, and salivation. Total score is the measure used, range 0-40; higher scores indicate increased severity of signs. (NCT02129348)
Timeframe: Assessed at Week 0, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | -0.0 |
| Placebo Group | 0.0 |
Treatment Emergent Symptom Scale that covers 26 somatic symptoms, each rated as present (score=1) or absent (score=0). Total score is the measure used with scoring range 0-26; higher scores indicate more somatic symptoms. (NCT02129348)
Timeframe: Assessed at Week 0, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | 0.6 |
| Placebo Group | 0.7 |
Young Mania Rating Scale total score is the measure used to assess symptoms that occur in mania; each item is a symptom that is rated for severity. Scoring range 0-60; higher scores indicate more severe symptoms. (NCT02129348)
Timeframe: Assessed at Week 0, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | 3.1 |
| Placebo Group | 1.1 |
Zarit Caregiver Burden Interview with the caregiver asked to rank 22 items on a scale with responses for each item from 'never' (score 0) to 'nearly always' (score 4). Total score is the measure used; range 0-88 with higher scores indicating greater caregiver burden. (NCT02129348)
Timeframe: Assessed at Week 0, Week 4, Week 8, Week 10, Week 12
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Lithium Treatment Group | 2.8 |
| Placebo Group | -0.4 |
"The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) test will characterize the neuropsychiatric and psychopathological symptoms of patients affected by dementia.~Events as delirium, anxiety, depression, etc. will be recorded by the frequency (from 0, absence, to 4, high frequency) and the seriousness (from 0, absence, to 3, high). The total score of the NPI-NH is given by the frequency x (multiply) seriousness (total score for each event has a range from 0 to 12). The patient final score will be given by the sum of the score of the 12 events. For each patient will be given a total score from 0 to 144.~NPI NH score has been collected in both control and aromatherapy groups at T1 and T3, in patients who needed and who did not needed Pro Re Nata." (NCT03662360)
Timeframe: Time 1 (baseline) and Time 3 (day 7)
| Intervention | score on a scale (Mean) | ||
|---|---|---|---|
| T1 NPI score in patients do not need Pro Re Nata | T3 NPI score in patients needed Pro Re Nata | T3 NPI score in patients do not need Pro Re Nata | |
| GROUP A - Control Group | 21.81 | 32.87 | 20.00 |
| GROUP B - Aromatherapy Group | 25.93 | 16.5 | 7.25 |
NPI-NH assess the psychological distress in physicians, nurses and nursing assistants who managed the patients. It has a score from 0 (no discomfort) to score of 5 (extreme discomfort). The psychological distress is measured for each of the 12 events in the NPI-NH scale, for a total score from 0 to 60. (NCT03662360)
Timeframe: Time 1 (baseline) and Time 3 (day 7)
| Intervention | score on a scale (Mean) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T1 NPI NH physicians in pts with PRN | T1 NPI NH physicians in pts without PRN | T1 NPI NH nurses in pts with PRN | T1 NPI NH nurses in pts without PRN | T1 NPI NH nursing assistants in pts with PRN | T1 NPI NH nursing assistants in pts without PRN | T3 NPI NH physician in pts with PRN | T3 NPI NH physician in pts without PRN | T3 NPI NH nurses in pts with PRN | T3 NPI NH nurses in pts without PRN | T3 NPI NH nursing assistants in pts with PRN | T3 NPI NH nursing assistants in pts without PRN | |
| GROUP A - Control Group | 4.19 | 1.60 | 9.63 | 6.40 | 11.00 | 7.10 | 6.00 | 3.20 | 12.00 | 9.30 | 13.19 | 9.90 |
| GROUP B - Aromatherapy Group | 5.64 | 4.13 | 11.64 | 10.13 | 12.21 | 10.88 | 2.64 | 0.88 | 5.79 | 4.25 | 5.93 | 4.38 |
30 reviews available for haloperidol and Aggression
| Article | Year |
|---|---|
The Use of Rapid Tranquilization in Aggressive Behavior.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Psychomotor Agitation; Psych | 2019 |
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Dystonia; Haloperidol; Humans; Hypnotics and Sedatives; Placebos; | 2017 |
Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Injections, In | 2018 |
The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.
Topics: Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; H | 2019 |
Benzodiazepines for psychosis-induced aggression or agitation.
Topics: Acute Disease; Aggression; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Drug Thera | 2013 |
Capgras delusion with violent behavior in Alzheimer dementia: case analysis with literature review.
Topics: Aged; Aggression; Alzheimer Disease; Amitriptyline; Anticonvulsants; Antidepressive Agents, Tricycli | 2014 |
[Challenging behaviour in patients with intellectual disability].
Topics: Aggression; Agonistic Behavior; Child; Female; Haloperidol; Humans; Intellectual Disability; Male; M | 2014 |
Haloperidol plus promethazine for psychosis-induced aggression.
Topics: Aggression; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; P | 2016 |
Haloperidol for long-term aggression in psychosis.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Administration Schedule; H | 2016 |
Droperidol for psychosis-induced aggression or agitation.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Benzodiazepines; Droperidol; Haloperidol; Humans; M | 2016 |
[Clinical and therapeutic aspects of agitation].
Topics: Acute Disease; Aggression; Antipsychotic Agents; Benzodiazepines; Controlled Clinical Trials as Topi | 2007 |
Haloperidol plus promethazine for psychosis-induced aggression.
Topics: Aggression; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; O | 2009 |
Chlorpromazine for psychosis induced aggression or agitation.
Topics: Administration, Oral; Aggression; Antipsychotic Agents; Chlorpromazine; Haloperidol; Humans; Injecti | 2010 |
[Rapid tranquillisation; review of the literature and recommendations].
Topics: Aggression; Benzodiazepines; Conscious Sedation; Drug Therapy, Combination; Haloperidol; Humans; Hyp | 2011 |
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Dibenzothiazepines; | 2012 |
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazep | 2012 |
Haloperidol plus promethazine for psychosis induced aggression.
Topics: Aggression; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Promethazine; Psyc | 2005 |
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Injections, Intramuscular; L | 2005 |
[Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Olanzapine; Psycho | 2006 |
Pharmacologic approaches to violence.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Be | 1984 |
Lithium.
Topics: Aggression; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, C | 1984 |
Pharmacological, hormonal, and behavioral manipulations in analysis of aggressive behavior.
Topics: Aggression; Amphetamine; Animals; Castration; Endorphins; Ethanol; Female; Haloperidol; Hormones; Hu | 1984 |
Acute psychopharmacological management of the aggressive psychotic patient.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Huma | 1999 |
Atypical antipsychotic medications in the psychiatric emergency service.
Topics: Administration, Oral; Aggression; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedul | 2000 |
Haloperidol for agitation in dementia.
Topics: Aggression; Anti-Dyskinesia Agents; Dementia; Haloperidol; Humans; Psychomotor Agitation; Randomized | 2001 |
Haloperidol for agitation in dementia.
Topics: Aggression; Anti-Dyskinesia Agents; Dementia; Haloperidol; Humans; Psychomotor Agitation; Randomized | 2002 |
Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Butyrophenones; Clopenthixol; Double-Blin | 1992 |
Pharmacologic management of aggression in the elderly.
Topics: Aged; Aggression; Antipsychotic Agents; Benzodiazepines; Buspirone; Dementia; Haloperidol; Humans; L | 1990 |
Use of benzodiazepines to control disruptive behavior in inpatients.
Topics: Aggression; Benzodiazepines; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Loraze | 1988 |
The catecholamines and aggressive behavior.
Topics: Aggression; Amphetamine; Anger; Animals; Behavior, Animal; Brain Stem; Catecholamines; Dihydroxyphen | 1973 |
44 trials available for haloperidol and Aggression
| Article | Year |
|---|---|
Depression and impulsivity as pathways to violence: implications for antiaggressive treatment.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Depression; Double-Blind Method | 2014 |
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostilit | 2014 |
Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Conscious Sedation; Droperidol; Female; H | 2015 |
Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Double-Bli | 2008 |
Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.
Topics: Adult; Aggression; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body | 2009 |
Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).
Topics: Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Cost-Benefit Analysis; Dose-Response Rela | 2009 |
The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis.
Topics: Adult; Aggression; Antipsychotic Agents; Combined Modality Therapy; Cost-Benefit Analysis; Double-Bl | 2009 |
Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities.
Topics: Adult; Aggression; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Evid | 2010 |
Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Dru | 2011 |
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperid | 2011 |
Executive function predicts response to antiaggression treatment in schizophrenia: a randomized controlled trial.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Executive Function; Female; Hal | 2012 |
Reducing seclusion through involuntary medication: a randomized clinical trial.
Topics: Adult; Aggression; Antipsychotic Agents; Coercion; Drug Therapy, Combination; Female; Haloperidol; H | 2013 |
The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Chronic Disease; Clozapine; Diagnostic and Stat | 2003 |
Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.
Topics: Adult; Aggression; Drug Therapy, Combination; Emergency Service, Hospital; Emergency Services, Psych | 2003 |
Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Haloperidol; Huma | 2004 |
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepi | 2005 |
Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial.
Topics: Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Hal | 2006 |
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Female; Ha | 2006 |
Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Basal Ganglia Disea | 2008 |
Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine.
Topics: Adult; Aggression; Antipsychotic Agents; Drug Combinations; Emergency Services, Psychiatric; Haloper | 2007 |
Antipsychotic drugs for aggression in intellectual disability.
Topics: Aggression; Antipsychotic Agents; Haloperidol; Humans; Intellectual Disability; Risperidone | 2008 |
Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.
Topics: Adult; Aged; Aggression; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Mental Competency; | 2008 |
Electroencephalogram and treatment of hospitalized aggressive children with haloperidol or lithium.
Topics: Aggression; Child; Child Behavior Disorders; Child, Preschool; Clinical Trials as Topic; Electroence | 1983 |
Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder.
Topics: Aggression; Child; Child Behavior Disorders; Clinical Trials as Topic; Depressive Disorder; Double-B | 1984 |
Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children.
Topics: Aggression; Child; Child Behavior Disorders; Clinical Trials as Topic; Cognition; Concept Formation; | 1984 |
Cognitive effects of haloperidol and lithium in aggressive conduct-disorder children.
Topics: Aggression; Child; Child Behavior Disorders; Cognition; Female; Haloperidol; Humans; Lithium; Male; | 1984 |
Effects of lithium carbonate and haloperidol on cognition in aggressive hospitalized school-age children.
Topics: Aggression; Child; Child Behavior Disorders; Clinical Trials as Topic; Cognition; Double-Blind Metho | 1981 |
Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Basal Ganglia Diseases; Dementia; Dementia, | 1993 |
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.
Topics: Aged; Aggression; Alzheimer Disease; Ambulatory Care; Basal Ganglia Diseases; Brief Psychiatric Rati | 1998 |
Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.
Topics: Acute Disease; Adult; Aggression; Antipsychotic Agents; Brief Psychiatric Rating Scale; Double-Blind | 1999 |
Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Cognition Disorders; Double-Blind Method; | 2000 |
A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aggression; Brief Psychiatric Rating Scale; Clinical Trials as Top | 1977 |
Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
Topics: Acute Disease; Adult; Aged; Aggression; Biperiden; Clinical Trials as Topic; Dibenzoxazepines; Doubl | 1977 |
Methylphenidate and haloperidol in children. Effects on attention, memory, and activity.
Topics: Aggression; Attention; Child; Child, Preschool; Clinical Trials as Topic; Cognition; Dose-Response R | 1975 |
Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Butyrophenones; Clopenthixol; Double-Blin | 1992 |
Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
Topics: Adult; Aged; Aggression; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; H | 1992 |
Droperidol versus haloperidol for chemical restraint of agitated and combative patients.
Topics: Adult; Aggression; Blood Pressure; Double-Blind Method; Droperidol; Emergencies; Emergency Service, | 1992 |
Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
Topics: Acute Disease; Adult; Aggression; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combinati | 1991 |
Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Clinical Trials as Topic; Clopenthixol; D | 1989 |
A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aggression; Clinical Trials as Topic; | 1986 |
Paradoxical effects of amitriptyline on borderline patients.
Topics: Aggression; Amitriptyline; Borderline Personality Disorder; Clinical Trials as Topic; Double-Blind M | 1986 |
Haloperidol in the treatment of children with severe behaviour disorders.
Topics: Aggression; Child; Child Behavior Disorders; Clinical Trials as Topic; Haloperidol; Humans; Mental P | 1968 |
A controlled trial of haloperidol in children.
Topics: Adolescent; Aggression; Child; Child Behavior Disorders; Child, Preschool; Clinical Trials as Topic; | 1968 |
Clinical comparison of haloperidol with chlorpromazine in mentally retarded children.
Topics: Aggression; Child; Child Behavior Disorders; Child, Preschool; Chlorpromazine; Clinical Trials as To | 1971 |
119 other studies available for haloperidol and Aggression
| Article | Year |
|---|---|
Anabolic steroids-induced delirium: A case report.
Topics: Adult; Aggression; Antipsychotic Agents; Delirium; Haloperidol; Humans; Male; Quetiapine Fumarate; T | 2020 |
Risk and Prevention of Aggression in Patients With Psychotic Disorders.
Topics: Aggression; Clozapine; Conduct Disorder; Haloperidol; Humans; Olanzapine; Psychotic Disorders; Schiz | 2021 |
[Haloperidol and promethazine in psychotic aggression].
Topics: Aggression; Antipsychotic Agents; Drug Therapy, Combination; Haloperidol; Humans; Promethazine; Psyc | 2017 |
Behavioral effects of triadimefon in zebrafish are associated with alterations of the dopaminergic and serotonergic pathways.
Topics: Aggression; Animals; Anxiety; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dose-R | 2019 |
Stability of intraocular pressure after retinal reattachment surgery during electroconvulsive therapy for intractable self-injury in a 12-year-old autistic boy.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Autistic Disorder; Child; Electroconvulsive Thera | 2014 |
Managing severe aggression in frontotemporal dementia.
Topics: Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Cognition Disorders; Death; Fatal Outcome; | 2014 |
Is the use of haloperidol a safe and effective method of tranquilization for patients with psychosis-induced aggression or agitation?
Topics: Aggression; Antipsychotic Agents; Haloperidol; Humans; Psychomotor Agitation; Psychotic Disorders | 2014 |
[Effect of dopamine D1 and D2 receptor blockade on the immunostimulating effect of δ1 opioid receptor agonist DPDPE in mice with different psychoemotional states].
Topics: Aggression; Analgesics, Opioid; Animals; Benzazepines; Depression; Dopamine Antagonists; Enkephalin, | 2015 |
Use of haloperidol and risperidone in highly aggressive Swiss Webster mice by applying the model of spontaneous aggression (MSA).
Topics: Aggression; Animals; Exploratory Behavior; Haloperidol; Male; Mice; Models, Animal; Motor Activity; | 2016 |
Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury.
Topics: Aggression; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Brain Injuries; H | 2008 |
Effects of yokukansan, a traditional Japanese medicine, on aggressiveness induced by intracerebroventricular injection of amyloid beta protein into mice.
Topics: Aggression; Amyloid beta-Peptides; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug | 2009 |
Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
Topics: Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Dementia; Drug Approval; Europe; France; | 2009 |
An intoxicated man with facial trauma.
Topics: Aggression; Alcoholic Intoxication; Anti-Anxiety Agents; Antipsychotic Agents; Emergency Medical Ser | 2010 |
A prospective longitudinal study of cholesterol and aggression in patients randomized to clozapine, olanzapine, and haloperidol.
Topics: Aggression; Benzodiazepines; Cholesterol; Clozapine; Cross-Sectional Studies; Double-Blind Method; H | 2010 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diben | 2011 |
DIFFERENTIAL INTER-DRUG ANALYSIS: A PRELIMINARY STUDY.
Topics: Aggression; Biomedical Research; Chlorpromazine; Delusions; Haloperidol; Humans; Mental Disorders; P | 1964 |
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorde | 2003 |
Treatment of acute self-aggressive behaviour in a captive gorilla (Gorilla gorilla gorilla).
Topics: Aggression; Animals; Antipsychotic Agents; Anxiety; Ape Diseases; Female; Gorilla gorilla; Haloperid | 2004 |
Beyond haloperidol: teaching emergency medicine residents to manage acute agitation and aggression in the emergency department.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Emergency Medical Services; Emergency Medicine; Hal | 2004 |
Gabapentin for ultra resistant schizophrenia with aggressive behavior.
Topics: Adult; Aggression; Amines; Anticonvulsants; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Drug | 2008 |
[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
Topics: Adult; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzo | 2007 |
[Psychopharmacologic spectrum of melanostatin].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Biogenic Amines; Brain Chemistry; Catalepsy; Cats | 1980 |
Changes of response to dopaminergic drugs in rats submitted to REM-sleep deprivation.
Topics: Adrenergic Agonists; Aggression; Animals; Apomorphine; Bromocriptine; Haloperidol; Humans; Male; Pir | 1981 |
[Therapy with psychotropic drugs in children with "behavior disorders"].
Topics: Aggression; Amphetamines; Antipsychotic Agents; Child; Child Behavior Disorders; Chlorpromazine; Hal | 1981 |
[Effect of an imidazobenzodiazepine (RO 15-1788) on aggressive behavior in mice].
Topics: Aggression; Animals; Apomorphine; Benzodiazepinones; Brain; Catalepsy; Dose-Response Relationship, D | 1984 |
Increased shock-induced fighting with supersensitive beta-adrenergic receptors.
Topics: Aggression; Animals; Brain; Cell Membrane; Electroshock; Haloperidol; Humans; Male; Metoprolol; Pind | 1983 |
The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats.
Topics: Aggression; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Hum | 1983 |
Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors.
Topics: Aggression; alpha-Methyltyrosine; Animals; Catecholamines; Chlorpromazine; Clonidine; Dextroamphetam | 1984 |
[Pharmaco-ethological analysis of agonistic behavior between resident and intruder mice: effects of psychotropic drugs].
Topics: Aggression; Agonistic Behavior; Animals; Anxiety; Chlordiazepoxide; Female; Haloperidol; Hostility; | 1984 |
Possible dopaminergic involvement in biting compulsion induced by large doses of clonidine.
Topics: Aggression; Amphetamine; Animals; Clonidine; Clozapine; Dopamine; Drug Interactions; Female; Haloper | 1983 |
Evidence for central histaminergic mechanism in foot shock aggression.
Topics: Aggression; Amphetamine; Animals; Atropine; Electroshock; Female; Haloperidol; Histamine; Histamine | 1982 |
Influence of lisuride on morphine withdrawal signs in the rat: a dopamine-mimetic effect.
Topics: Aggression; Animals; Apomorphine; Dopamine; Ergolines; Haloperidol; Humans; Lisuride; Male; Morphine | 1982 |
An interdisciplinary approach to the diagnosis and management of a complex case of postencephalitic behavioral disorder.
Topics: Adolescent; Aggression; Anticonvulsants; Brain Damage, Chronic; Child Behavior Disorders; Encephalit | 1983 |
Effects of phencyclidine on aggressive behavior in mice.
Topics: Aggression; Animals; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Human | 1982 |
Effects of lithium carbonate and haloperidol on cognition in aggressive, hospitalized school age children [proceedings].
Topics: Aggression; Attention; Child; Cognition; Double-Blind Method; Female; Haloperidol; Hospitalization; | 1981 |
What do rats find rewarding in play fighting?--an analysis using drug-induced non-playful partners.
Topics: Aggression; Animals; Female; Haloperidol; Male; Play and Playthings; Rats; Reinforcement, Social; Sc | 1995 |
Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.
Topics: Aggression; Animals; Apomorphine; Benzodiazepinones; Brain Chemistry; Clozapine; Devazepide; Dizocil | 1995 |
Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.
Topics: Aggression; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Dopamine Agents; Haloperid | 1993 |
The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat.
Topics: Aggression; Amphetamine; Animals; Clozapine; Haloperidol; Male; Phencyclidine; Rats; Rats, Sprague-D | 1994 |
The jumpy janitor. Letter to an ethicist.
Topics: Aged; Aggression; Dementia; Ethics, Medical; Haloperidol; Humans; Inpatients; Long-Term Care; Male; | 1993 |
Antiaggressive and motor effects of haloperidol show different temporal patterns in the development of tolerance.
Topics: Aggression; Agonistic Behavior; Animals; Arousal; Brain; Dose-Response Relationship, Drug; Drug Admi | 1993 |
Chronic treatment with eltoprazine does not lead to tolerance in its anti-aggressive action, in contrast to haloperidol.
Topics: Aggression; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Haloperidol | 1996 |
Assessment of children with the overt aggression scale.
Topics: Aggression; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Female; Haloperidol; H | 1996 |
Anxiolytic-like effects of perospirone, a novel serotonin-2 and dopamine-2 antagonist (SDA)-type antipsychotic agent.
Topics: Aggression; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Dopamine Antagonists; Dose | 1998 |
S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloper
Topics: Aggression; Animals; Antipsychotic Agents; Autoreceptors; Clorazepate Dipotassium; Clozapine; Columb | 1999 |
Quantification of behaviour in social colonies of rhesus monkey.
Topics: Aggression; Amphetamine; Animals; Central Nervous System Stimulants; Dopamine Antagonists; Feeding B | 1997 |
Effect of prenatal diazepam, phenobarbital, haloperidol and fluoxetine exposure on foot shock induced aggression in rats.
Topics: Aggression; Animals; Diazepam; Drug Evaluation, Preclinical; Electroshock; Female; Fluoxetine; Halop | 1998 |
Effects of haloperidol on communicative and aggressive behavior in male mice with different experiences of aggression.
Topics: Aggression; Animal Communication; Animals; Behavior, Animal; Dopamine Antagonists; Dose-Response Rel | 1999 |
Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice.
Topics: Aggression; Animals; Antipsychotic Agents; Benzazepines; Dopamine Antagonists; Haloperidol; Male; Mi | 1999 |
S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multipara
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Antagon | 2000 |
The serotonin 5-HT(2A) receptor subtype does not mediate apomorphine-induced aggressive behaviour in male Wistar rats.
Topics: Aggression; Animals; Apomorphine; Behavior, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antag | 2000 |
The effects of apomorphine and haloperidol on memory consolidation in the day-old chick.
Topics: Age Factors; Aggression; Animals; Apomorphine; Avoidance Learning; Brain; Chickens; Conditioning, Cl | 2001 |
The use of haloperidol during the transport of adult ostriches.
Topics: Aggression; Animals; Antipsychotic Agents; Behavior, Animal; Female; Haloperidol; Injections, Intram | 2001 |
Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study.
Topics: Aggression; Benzodiazepines; Brazil; Clinical Protocols; Drug Combinations; Drug Utilization; Emerge | 2002 |
Pharmacologic management of children with hyperactive/aggressive/inattentive behavior disorders. Suggestions for the pediatrician.
Topics: Age Factors; Aggression; Antidepressive Agents, Tricyclic; Attention; Central Nervous System Stimula | 1976 |
Reactivity and aggression in the rat: induction by alpha-adrenergic blocking agents injected ventral to anterior septum but not into lateral septum.
Topics: Adrenergic alpha-Antagonists; Aggression; Anesthesia, Local; Animals; Atropine; Haloperidol; Humans; | 1977 |
Drug intervention in the management of aggression and explosive behaviour.
Topics: Aggression; Antipsychotic Agents; Haloperidol; Humans; Hypotension, Orthostatic; Injections, Intramu | 1978 |
Involvement of biogenic amines in drug-induced aggressive pecking in chicks.
Topics: Aggression; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Amines; Chickens; Dextroamphe | 1975 |
A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
Topics: Aggression; Amphetamine; Analgesics, Opioid; Animals; Apomorphine; Behavior, Animal; Brain; Cataleps | 1975 |
Drug interaction between haloperidol and methyldopa.
Topics: Aged; Aggression; Drug Interactions; Female; Haloperidol; Humans; Mental Disorders; Methyldopa | 1979 |
The effect of lithium on chronic haloperidol enhanced apomorphine aggression in rats.
Topics: Aggression; Animals; Apomorphine; Drug Interactions; Haloperidol; Humans; Lithium; Male; Rats; Stere | 1979 |
GABA in the ventral tegmental area: differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists.
Topics: Aggression; Animals; Apomorphine; Behavior, Animal; Bicuculline; Carbachol; Cerebral Cortex; Dopamin | 1979 |
[The influence of neuroleptics on the emotional anger reaction in animals].
Topics: Aggression; Anger; Animals; Cats; Chlorpromazine; Electroencephalography; Haloperidol; Humans; Tranq | 1975 |
An operant counting scale for children: A preliminary methodological psychoactive-drug case study.
Topics: Adolescent; Aggression; Anxiety Disorders; Child; Child Behavior Disorders; Dependency, Psychologica | 1975 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Ca | 1975 |
[The effect of pharmacologic substances on intraspecies aggression].
Topics: Aggression; Amitriptyline; Animals; Benactyzine; Chlordiazepoxide; Chlorpromazine; Diazepam; Haloper | 1975 |
DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.
Topics: Aggression; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Chlorp | 1992 |
Rapid tranquillisation.
Topics: Aggression; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emergencies; Halo | 1992 |
Psychopharmacogenetic aspects of Prader-Willi syndrome.
Topics: Adolescent; Aggression; Appetite Depressants; Behavior Therapy; Carbamazepine; Combined Modality The | 1992 |
[Effects of haloperidol on extracellular contents of dopamine and its metabolites in the septum of rats during interspecies aggression].
Topics: 3,4-Dihydroxyphenylacetic Acid; Aggression; Animals; Chromatography, High Pressure Liquid; Dopamine; | 1992 |
Changes at cholecystokinin receptors induced by long-term treatment with diazepam and haloperidol.
Topics: Aggression; Animals; Behavior, Animal; Ceruletide; Dextroamphetamine; Diazepam; Electroshock; Halope | 1992 |
Pharmacological effects on two inbred substrains of AB mice.
Topics: Aggression; Animals; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Haloperidol; Hexo | 1991 |
D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Affect; Aggression; Analysis of Variance | 1991 |
Effects of serotonergic agents on isolation-induced aggression.
Topics: Aggression; Animals; Anti-Anxiety Agents; Benzamides; Benzodiazepines; Bridged Bicyclo Compounds; Br | 1991 |
Applying a DRO schedule and compliance training to reduce aggressive and self-injurious behavior in an autistic man: a case report.
Topics: Adult; Aggression; Autistic Disorder; Behavior Therapy; Carbamazepine; Combined Modality Therapy; Ha | 1991 |
Nicardipine protects against chronic ethanol- or haloperidol-induced supersensitivity to apomorphine-induced aggression.
Topics: Aggression; Animals; Apomorphine; Behavior, Animal; Drug Interactions; Ethanol; Haloperidol; Male; N | 1991 |
[Serenics. A new drug group with specific anti-aggressive effect].
Topics: Aggression; Animals; Haloperidol; Humans; Mice; Piperazines; Psychotropic Drugs; Rats | 1991 |
Tardive eating dystonia.
Topics: Aged; Aggression; Blepharospasm; Deglutition Disorders; Dyskinesia, Drug-Induced; Feeding and Eating | 1990 |
Haloperidol does not antagonize the effects of stress on aggressive behaviour in mice.
Topics: Aggression; Agonistic Behavior; Animals; Arousal; Dose-Response Relationship, Drug; Haloperidol; Mal | 1990 |
A case of Tourette syndrome developing during haloperidol treatment.
Topics: Aggression; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combina | 1990 |
Magnesium alters the potency of cocaine and haloperidol on mouse aggression.
Topics: Aggression; Animals; Cocaine; Diet; Dose-Response Relationship, Drug; Drug Synergism; Female; Halope | 1989 |
[Clopheline-induced aggression in mice: role of genotype and the dopaminergic system].
Topics: Aggression; Animals; Apomorphine; Bromocriptine; Clonidine; Flupenthixol; Genotype; Haloperidol; Mal | 1989 |
The dangerous patient.
Topics: Adult; Aggression; California; Confidentiality; Dangerous Behavior; Forensic Medicine; Haloperidol; | 1989 |
Automated method for measuring fighting behavior and locomotor activity of mice.
Topics: Aggression; Animals; Behavior, Animal; Data Collection; Dextroamphetamine; Evaluation Studies as Top | 1989 |
Inhibitory effects of carbamazepine on clonidine-induced aggressive behavior in mice.
Topics: Adenosine; Aggression; Animals; Behavior, Animal; Caffeine; Carbamazepine; Clonidine; Haloperidol; M | 1988 |
Influence of imidazole on behavioral effects induced by dopaminergic agonists in rats.
Topics: Adrenergic Agonists; Aggression; Animals; Behavior, Animal; Dopamine; Female; Haloperidol; Humans; I | 1985 |
1.2-Anellated 1.4-benzodiazepine derivatives--a new class of antipsychotics.
Topics: Aggression; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Apomorphine; Arousal; Behavior, Anim | 1985 |
Aggressive behavior in Huntington's disease: treatment with propranolol.
Topics: Adult; Aggression; Antipsychotic Agents; Drug Therapy, Combination; Haloperidol; Humans; Huntington | 1987 |
Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder.
Topics: Acute Disease; Adolescent; Aggression; Akathisia, Drug-Induced; Antipsychotic Agents; Child; Child, | 1988 |
Interactive effects of caffeine, 2-chloroadenosine and haloperidol on activity, social investigation and play fighting of juvenile rats.
Topics: 2-Chloroadenosine; Adenosine; Aggression; Animals; Caffeine; Dose-Response Relationship, Drug; Drug | 1985 |
[Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Catalepsy; Central Nervous System; Dronabinol; Ha | 1985 |
Facilitatory effects of caerulein on hypothalamic defensive attack in cats.
Topics: Aggression; Agonistic Behavior; Animals; Behavior, Animal; Cats; Ceruletide; Dose-Response Relations | 1988 |
Diltiazem suppresses apomorphine-induced fighting and pro-aggressive effect of withdrawal from chronic ethanol or haloperidol in rats.
Topics: Aggression; Animals; Apomorphine; Behavior, Animal; Calcium Channel Blockers; Diltiazem; Drug Intera | 1988 |
Antiaggressive effect of adjunctive clonazepam in schizophrenia associated with seizure disorder.
Topics: Adult; Aggression; Clonazepam; Drug Therapy, Combination; Electroconvulsive Therapy; Epilepsy, Tempo | 1988 |
[Phenomenology of tics: psychological and psychiatric approach].
Topics: Aggression; Cognition; Feeding Behavior; Haloperidol; Humans; Phobic Disorders; Sexual Behavior; Tou | 1986 |
Imidazole modification of aggressive behaviour in rats and mice.
Topics: Aggression; Animals; Haloperidol; Imidazoles; Lisuride; Male; Mice; Morphine Dependence; Rats; Rats, | 1987 |
Effects of d,1-propranolol and haloperidol on aggressive behavior induced in mice by isolation and isolation plus amphetamine treatment.
Topics: Aggression; Agonistic Behavior; Amphetamine; Animals; Haloperidol; Mice; Propranolol; Social Isolati | 1986 |
Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated.
Topics: Activities of Daily Living; Aged; Aggression; Cognition Disorders; Confusion; Female; Haloperidol; H | 1986 |
Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated.
Topics: Activities of Daily Living; Aged; Aggression; Cognition Disorders; Confusion; Female; Haloperidol; H | 1986 |
Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated.
Topics: Activities of Daily Living; Aged; Aggression; Cognition Disorders; Confusion; Female; Haloperidol; H | 1986 |
Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated.
Topics: Activities of Daily Living; Aged; Aggression; Cognition Disorders; Confusion; Female; Haloperidol; H | 1986 |
The cholecystokinin-like peptide, ceruletide, reduces isolation-induced aggression in mice.
Topics: Aggression; Animals; Ceruletide; Depression, Chemical; Diazepam; Haloperidol; Male; Mice; Social Iso | 1986 |
The daughter as the principal "double" in a Capgras' syndrome: psychodynamic correlates.
Topics: Adolescent; Adult; Aggression; Capgras Syndrome; Combined Modality Therapy; Female; Haloperidol; Hum | 1986 |
Effects of dopamine agonists on hypothalamic defensive attack in cats.
Topics: Aggression; Agonistic Behavior; Animals; Apomorphine; Cats; Chlorpromazine; Diazepam; Dopamine; Halo | 1985 |
Pharmacokinetics and effects of haloperidol in the isolated mouse.
Topics: Aggression; Animals; Brain; Catalepsy; Haloperidol; Kinetics; Male; Methylphenidate; Mice; Social Is | 1985 |
Antagonism of picrotoxin against the taming effect of carbamazepine on footshock induced fighting behavior in mice.
Topics: Aggression; Animals; Bicuculline; Carbamazepine; Diazepam; Electroshock; gamma-Aminobutyric Acid; Ha | 1985 |
An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
Topics: 5-Hydroxytryptophan; Aggression; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Bens | 1974 |
Treatment of Gilles de la Tourette's Syndrome with haloperidol.
Topics: Adult; Aggression; Child; Female; Haloperidol; Humans; Male; MMPI; Tourette Syndrome | 1968 |
Effect of some psychotropic drugs on mice from a spontaneously aggressive strain.
Topics: Aggression; Animals; Chlorpromazine; Diazepam; Haloperidol; Humans; Imipramine; Indoles; Male; Mepro | 1968 |
Effect of dopaminergic stimulation or blockade on morphine-withdrawal aggression.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Dihydroxyphenylalanine; Haloperidol; Humans; Male; Me | 1973 |
The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
Topics: Aggression; Amphetamine; Animals; Brain; Catalepsy; Chlorpromazine; Dopamine; Haloperidol; Humans; M | 1973 |
Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol.
Topics: Administration, Oral; Aggression; Animals; Apomorphine; Behavior, Animal; Body Temperature; Dopamine | 1974 |
[Effect of neuroleptics and tranquilizers on the content of free and bound noradrenaline fractions in the rat brain stem during aggression].
Topics: Aggression; Animals; Brain Stem; Haloperidol; Humans; Male; Norepinephrine; Rats; Tranquilizing Agen | 1972 |
[Effect of antidepressants and neuroleptics on emotional reactions caused by cholinergic stimulation of the hypothalamus and mesencephalon].
Topics: Acetylcholine; Aggression; Amitriptyline; Animals; Antidepressive Agents; Benactyzine; Cats; Chlordi | 1972 |
The management of excitement in a general hospital psychiatric ward by high dosage haloperidol.
Topics: Administration, Oral; Adult; Aggression; Evaluation Studies as Topic; Female; Haloperidol; Hospitals | 1971 |
Comparison of haloperidol and fluphenazine in disturbed children.
Topics: Aggression; Anxiety; Autistic Disorder; Child; Child, Preschool; Female; Fluphenazine; Haloperidol; | 1970 |
Aroylpiperidines and pyrrolidines. A new class of potent central nervous system depressants.
Topics: Action Potentials; Aggression; Alkylation; Animals; Butyrophenones; Central Nervous System; Chlorpro | 1970 |
[The appearance of threat and flight reactions evoked by stimulation of the anterior hypothalamus of cats against a background of psychotropic drug action].
Topics: Aggression; Animals; Benactyzine; Cats; Chlordiazepoxide; Chlorpromazine; Electric Stimulation; Esca | 1970 |
[Intraspecific aggressive behavior induced by apomorphine in the rat].
Topics: Acepromazine; Age Factors; Aggression; Amitriptyline; Animals; Apomorphine; Atropine; Behavior, Anim | 1970 |
Effects of various drugs on 3,4-dihydroxyphenylalanine (DL-DOPA)-induced excitation (agressive behavior) in mice.
Topics: Aggression; Animals; Antidepressive Agents; Autonomic Agents; Behavior, Animal; Bretylium Compounds; | 1970 |
[Features of a reaction to intravenous haloperidol administration].
Topics: Adult; Aggression; Alcoholism; Anxiety; Depression; Hallucinations; Haloperidol; Humans; Injections, | 1971 |
New experimental aspects concerning haloperidol action on rat behaviour.
Topics: Aggression; Animals; Central Nervous System; Conditioning, Classical; Depression, Chemical; Electric | 1968 |